We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Will Pay $97 Million to Put Kickback Investigation to Rest
Gilead Will Pay $97 Million to Put Kickback Investigation to Rest
Gilead Sciences has agreed to pay $97 million to settle Department of Justice (DOJ) claims that it illegally channeled Medicare copays for its pulmonary arterial hypertension (PAH) drug Letairis (ambrisentan) through a charitable foundation.